Click here to get full coverage on Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update  PR Newswire

Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Click here to get full coverage on QTTB Stock Surges: Market Insight - StocksToTrade

QTTB Stock Surges: Market Insight  StocksToTrade

QTTB Stock Surges: Market Insight - StocksToTrade

Click here to get full coverage on Q32 Bio Stock (QTTB) Opinions on ADX-097 Asset Sale | QTTB Stock News - Quiver Quantitative

Q32 Bio Stock (QTTB) Opinions on ADX-097 Asset Sale | QTTB Stock News  Quiver Quantitative

Q32 Bio Stock (QTTB) Opinions on ADX-097 Asset Sale | QTTB Stock News - Quiver Quantitative

Click here to get full coverage on QTTB Stock Faces Volatile Swings Amid Market Turmoil - timothysykes.com

QTTB Stock Faces Volatile Swings Amid Market Turmoil  timothysykes.com

QTTB Stock Faces Volatile Swings Amid Market Turmoil - timothysykes.com

Click here to get full coverage on Q32 Bio (QTTB) Price Target Increased by 13.33% to 11.56 - Nasdaq

Q32 Bio (QTTB) Price Target Increased by 13.33% to 11.56  Nasdaq

Q32 Bio (QTTB) Price Target Increased by 13.33% to 11.56 - Nasdaq

Click here to get full coverage on Q32 Bio Sells Complement Inhibitor ADX-097 - PR Newswire

Q32 Bio Sells Complement Inhibitor ADX-097  PR Newswire

Q32 Bio Sells Complement Inhibitor ADX-097 - PR Newswire

Click here to get full coverage on Q32 Bio (NASDAQ: QTTB) completes SIGNAL-AA Part B with 33 patients; topline mid-2026 - Stock Titan

Q32 Bio (NASDAQ: QTTB) completes SIGNAL-AA Part B with 33 patients; topline mid-2026  Stock Titan

Q32 Bio (NASDAQ: QTTB) completes SIGNAL-AA Part B with 33 patients; topline mid-2026 - Stock Titan

Click here to get full coverage on QTTB Stock Explodes Nearly 95%: Akebia Deal Transforms Q32 Bio’s Future - Bitget

QTTB Stock Explodes Nearly 95%: Akebia Deal Transforms Q32 Bio’s Future  Bitget

QTTB Stock Explodes Nearly 95%: Akebia Deal Transforms Q32 Bio’s Future - Bitget

Click here to get full coverage on Why Is Q32 Bio Stock (QTTB) Up Today? - TipRanks

Why Is Q32 Bio Stock (QTTB) Up Today?  TipRanks

Why Is Q32 Bio Stock (QTTB) Up Today? - TipRanks

Click here to get full coverage on Q32 Bio Insiders Benefit From Selling Stock At US$2.86 - simplywall.st

Q32 Bio Insiders Benefit From Selling Stock At US$2.86  simplywall.st

Q32 Bio Insiders Benefit From Selling Stock At US$2.86 - simplywall.st

Click here to get full coverage on This Penny Biotech Stock Just Doubled on a Key Acquisition. Should You Buy Shares Here? - Yahoo Finance

This Penny Biotech Stock Just Doubled on a Key Acquisition. Should You Buy Shares Here?  Yahoo Finance

This Penny Biotech Stock Just Doubled on a Key Acquisition. Should You Buy Shares Here? - Yahoo Finance

Click here to get full coverage on $QTTB stock is up 19% today. Here's what we see in our data. - Quiver Quantitative

$QTTB stock is up 19% today. Here's what we see in our data.  Quiver Quantitative

$QTTB stock is up 19% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Q32 Bio (QTTB) Q2 Loss Drops 45% - Nasdaq

Q32 Bio (QTTB) Q2 Loss Drops 45%  Nasdaq

Q32 Bio (QTTB) Q2 Loss Drops 45% - Nasdaq

Click here to get full coverage on QTTB Stock Surge: Buy or Wait? - timothysykes.com

QTTB Stock Surge: Buy or Wait?  timothysykes.com

QTTB Stock Surge: Buy or Wait? - timothysykes.com

Click here to get full coverage on Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update  PR Newswire

Q32 Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Click here to get full coverage on $QTTB stock is up 94% today. Here's what we see in our data. - Quiver Quantitative

$QTTB stock is up 94% today. Here's what we see in our data.  Quiver Quantitative

$QTTB stock is up 94% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq

Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation  Nasdaq

Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq

Click here to get full coverage on Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update  PR Newswire

Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

Click here to get full coverage on Q32 Bio Inc. Stock (QTTB) Opinions on Wells Fargo Healthcare Conference Participation - Quiver Quantitative

Q32 Bio Inc. Stock (QTTB) Opinions on Wells Fargo Healthcare Conference Participation  Quiver Quantitative

Q32 Bio Inc. Stock (QTTB) Opinions on Wells Fargo Healthcare Conference Participation - Quiver Quantitative

Click here to get full coverage on Morning Market Movers: QTTB, NFE, WBUY, KALA See Big Swings - RTTNews

Morning Market Movers: QTTB, NFE, WBUY, KALA See Big Swings  RTTNews

Morning Market Movers: QTTB, NFE, WBUY, KALA See Big Swings - RTTNews

Click here to get full coverage on Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata - PR Newswire

Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata  PR Newswire

Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata - PR Newswire

Click here to get full coverage on Q32 Bio Trades At Lows While Betting On Immune Breakthroughs - Finimize

Q32 Bio Trades At Lows While Betting On Immune Breakthroughs  Finimize

Q32 Bio Trades At Lows While Betting On Immune Breakthroughs - Finimize

Click here to get full coverage on Setup Watch: Will QTTB stock outperform tech sector in 2025 - Gold Moves & Low Drawdown Investment Strategies - moha.gov.vn

Setup Watch: Will QTTB stock outperform tech sector in 2025 - Gold Moves & Low Drawdown Investment Strategies  moha.gov.vn

Setup Watch: Will QTTB stock outperform tech sector in 2025 - Gold Moves & Low Drawdown Investment Strategies - moha.gov.vn

Click here to get full coverage on QTTB - Q32 BIO INC Latest Stock News & Market Updates - Stock Titan

QTTB - Q32 BIO INC Latest Stock News & Market Updates  Stock Titan

QTTB - Q32 BIO INC Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M - Stocktwits

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M  Stocktwits

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M - Stocktwits

Click here to get full coverage on Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga

Why Is Small-Cap Q32 Bio Stock Soaring On Monday?  Benzinga

Why Is Small-Cap Q32 Bio Stock Soaring On Monday? - Benzinga

Click here to get full coverage on Q32 Bio CEO Morrison sells $77870 in stock - Investing.com

Q32 Bio CEO Morrison sells $77870 in stock  Investing.com

Q32 Bio CEO Morrison sells $77870 in stock - Investing.com

Click here to get full coverage on Q32 Bio skyrockets as it sells complement inhibitor ADX-097 - The Pharma Letter

Q32 Bio skyrockets as it sells complement inhibitor ADX-097  The Pharma Letter

Q32 Bio skyrockets as it sells complement inhibitor ADX-097 - The Pharma Letter

Click here to get full coverage on Q32 Bio Sells ADX-097 to Akebia Therapeutics - TipRanks

Q32 Bio Sells ADX-097 to Akebia Therapeutics  TipRanks

Q32 Bio Sells ADX-097 to Akebia Therapeutics - TipRanks

Click here to get full coverage on All You Need to Know About Q32 Bio (QTTB) Rating Upgrade to Buy - Yahoo Finance

All You Need to Know About Q32 Bio (QTTB) Rating Upgrade to Buy  Yahoo Finance

All You Need to Know About Q32 Bio (QTTB) Rating Upgrade to Buy - Yahoo Finance

Click here to get full coverage on Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia - MSN

Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia  MSN

Q32 Bio Shares Soar After Offloading Phase 2 Complement Drug to Akebia - MSN

Click here to get full coverage on Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target - Investing.com

Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target  Investing.com

Oppenheimer maintains Outperform rating on Q32 Bio stock at $20 target - Investing.com

Click here to get full coverage on Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook - TechStock²

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook  TechStock²

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook - TechStock²

Click here to get full coverage on What risks investors should watch in QTTB stock - Profit Target & Technical Confirmation Trade Alerts - Улправда

What risks investors should watch in QTTB stock - Profit Target & Technical Confirmation Trade Alerts  Улправда

What risks investors should watch in QTTB stock - Profit Target & Technical Confirmation Trade Alerts - Улправда

Click here to get full coverage on QTTB stock touches 52-week low at $2.59 amid market challenges - Investing.com

QTTB stock touches 52-week low at $2.59 amid market challenges  Investing.com

QTTB stock touches 52-week low at $2.59 amid market challenges - Investing.com

Click here to get full coverage on Lee Kalowski, Q32 Bio CFO, sells $31k in shares - Investing.com

Lee Kalowski, Q32 Bio CFO, sells $31k in shares  Investing.com

Lee Kalowski, Q32 Bio CFO, sells $31k in shares - Investing.com

Click here to get full coverage on Q32 Bio Retains Mark Iwicki as Board Chair - TipRanks

Q32 Bio Retains Mark Iwicki as Board Chair  TipRanks

Q32 Bio Retains Mark Iwicki as Board Chair - TipRanks

Click here to get full coverage on Q32 Bio stock rockets after selling Phase 2 complement inhibitor to Akebia - Investing.com India

Q32 Bio stock rockets after selling Phase 2 complement inhibitor to Akebia  Investing.com India

Q32 Bio stock rockets after selling Phase 2 complement inhibitor to Akebia - Investing.com India

Click here to get full coverage on Q32 Bio receives Nasdaq noncompliance notice - Investing.com

Q32 Bio receives Nasdaq noncompliance notice  Investing.com

Q32 Bio receives Nasdaq noncompliance notice - Investing.com

Click here to get full coverage on Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million - PR Newswire

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million  PR Newswire

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million - PR Newswire

Click here to get full coverage on Q32 Bio lays off staff, focuses on alopecia program - The Pharma Letter

Q32 Bio lays off staff, focuses on alopecia program  The Pharma Letter

Q32 Bio lays off staff, focuses on alopecia program - The Pharma Letter

Click here to get full coverage on Q32 Bio (QTTB) Q2 Loss Drops 45% - sharewise.com

Q32 Bio (QTTB) Q2 Loss Drops 45%  sharewise.com

Q32 Bio (QTTB) Q2 Loss Drops 45% - sharewise.com

Click here to get full coverage on Q32 Bio Inc. (QTTB) - Zacks Investment Research

Q32 Bio Inc. (QTTB)  Zacks Investment Research

Q32 Bio Inc. (QTTB) - Zacks Investment Research

Click here to get full coverage on QTTB Stock Price and Chart — NASDAQ:QTTB - TradingView — Track All Markets

QTTB Stock Price and Chart — NASDAQ:QTTB  TradingView — Track All Markets

QTTB Stock Price and Chart — NASDAQ:QTTB - TradingView — Track All Markets

Click here to get full coverage on Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary - Yahoo Finance

Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary  Yahoo Finance

Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary - Yahoo Finance

Click here to get full coverage on Q32 Bio Stock Plunges After Analyst Downgrades, Price-Target Slashes Over Alopecia Data: Retail Confidence Drops - Stocktwits

Q32 Bio Stock Plunges After Analyst Downgrades, Price-Target Slashes Over Alopecia Data: Retail Confidence Drops  Stocktwits

Q32 Bio Stock Plunges After Analyst Downgrades, Price-Target Slashes Over Alopecia Data: Retail Confidence Drops - Stocktwits

Click here to get full coverage on Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday - Yahoo Finance

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday  Yahoo Finance

Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday - Yahoo Finance

Click here to get full coverage on BMO Capital Initiates Coverage of Q32 Bio (QTTB) with Outperform Recommendation - Nasdaq

BMO Capital Initiates Coverage of Q32 Bio (QTTB) with Outperform Recommendation  Nasdaq

BMO Capital Initiates Coverage of Q32 Bio (QTTB) with Outperform Recommendation - Nasdaq

Click here to get full coverage on StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results - Genetic Engineering and Biotechnology News

StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results  Genetic Engineering and Biotechnology News

StockWatch: Q32 Shares Crater 85% as Investors, Analysts Sour on Trial Results - Genetic Engineering and Biotechnology News

Click here to get full coverage on Biotech Slaughtered, Down 76%, On A 'Messy' Update - Investor's Business Daily

Biotech Slaughtered, Down 76%, On A 'Messy' Update  Investor's Business Daily

Biotech Slaughtered, Down 76%, On A 'Messy' Update - Investor's Business Daily

Click here to get full coverage on Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 (NASDAQ:QTTB) - Seeking Alpha

Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 (NASDAQ:QTTB)  Seeking Alpha

Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 (NASDAQ:QTTB) - Seeking Alpha

Click here to get full coverage on Q32 Bio stock target cut, rating held on trial results - Investing.com

Q32 Bio stock target cut, rating held on trial results  Investing.com

Q32 Bio stock target cut, rating held on trial results - Investing.com

Click here to get full coverage on Homology enters reverse merger with Q32 Bio - BioPharma Dive

Homology enters reverse merger with Q32 Bio  BioPharma Dive

Homology enters reverse merger with Q32 Bio - BioPharma Dive

Click here to get full coverage on Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer - citybiz

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer  citybiz

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer - citybiz

Click here to get full coverage on Q32 Bio Stock Plunges After Analyst Downgrades, Price-Target Slashes Over Alopecia Data: Retail Confidence Drops - Asianet Newsable

Q32 Bio Stock Plunges After Analyst Downgrades, Price-Target Slashes Over Alopecia Data: Retail Confidence Drops  Asianet Newsable

Q32 Bio Stock Plunges After Analyst Downgrades, Price-Target Slashes Over Alopecia Data: Retail Confidence Drops - Asianet Newsable

Click here to get full coverage on Q32 Bio Inc. (QTTB) Stock: Jumps on Akebia Acquisition of ADX-097 and Extended Runway - parameter.io

Q32 Bio Inc. (QTTB) Stock: Jumps on Akebia Acquisition of ADX-097 and Extended Runway  parameter.io

QTTB

Price Chart

Key Statistics

Technicals

About QTTB

Latest News

Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

QTTB Stock Surges: Market Insight - StocksToTrade

Q32 Bio Stock (QTTB) Opinions on ADX-097 Asset Sale | QTTB Stock News - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers